Background
Methods
Study design, Population & Setting
Data sources and variables
Statistical analyses
Availability of data and materials
Results
Categories | N = 368 N (%) |
---|---|
Admission Diagnosis | |
Related to lung cancer | 81 (20.3) |
Acute cardiac decompensation | 43 (10.8) |
Chest infection | 109 (27.4) |
Related to surgical treatment | 61 (15.3) |
Unrelated to lung cancer | 104 (26.1) |
Cardiac Arrest Precipitating Admission | |
Prior CPR | 29 (7.3) |
No prior CPR | 369 (92.7) |
APACHE II Score | |
8–12 | 20 (5.0) |
13–17 | 67 (16.8) |
18–22 | 77 (19.4) |
23–27 | 74 (18.6) |
≥ 28 | 55 (13.8) |
Missing | 105 (26.4) |
Admission Specialty | |
Medical | 134 (33.7) |
Surgical | 264 (66.3) |
Number of Organs Supported | |
None | 79 (19.9) |
1 | 94 (23.6) |
2 | 138 (34.7) |
3 | 25 (6.3) |
Not known | 62 (15.6) |
Receipt of Mechanical Ventilation | |
No | 99 (24.9) |
Yes | 282 (70.9) |
Not known | 17 (4.3) |
Receipt of Renal Replacement Therapy | |
No | 322 (80.9) |
Yes | 27 (6.8) |
Not known | 49 (12.3) |
Receipt of Vasoactive Agents | |
No | 183 (46.0) |
Yes | 182 (45.7) |
Not known | 33 (8.3) |
Charlson Co-Morbidity Index | |
0 | 239 (60.1) |
≥ 1 | 159 (39.9) |
Length of stay | |
ICU | 3 days (IQR 1–6) |
Hospital | 10 days (IQR 1–19) |
Mortality | |
ICU | 165 (41.5) |
Hospital | 231 (58.0) |
Six-month | 274 (68.8) |
ICU Admissions N = 398 n (%) | Non-admissions N = 26,333 n (%) | P value | |
---|---|---|---|
Age at Incidence | |||
Mean (SD) | 67 (SD 8.8) | 71 (SD 10.3) | < 0.001 |
Sex | |||
Male | 246 (61.8) | 14,085 (53.5) | 0.001 |
Female | 152 (38.2) | 12,248 (46.5) | |
SIMD Quintile | |||
1 (Most deprived) | 146 (36.7) | 10,691 (40.6) | 0.350a |
2 | 106 (26.6) | 6692 (25.4) | |
3 | 73 (18.3) | 4108 (15.6) | |
4 | 43 (10.8) | 2739 (10.4) | |
5 (Most affluent) | 30 (7.5) | 2103 (8.0) | |
Histology | |||
SCLC | 32 (8.0) | 4222 (16.0) | < 0.001 |
NSCLC | 366 (92.0) | 22,111 (84.0) | |
Charlson Co-Morbidity Index | |||
0 | 239 (60.1) | 16,894 (64.2) | 0.090 |
≥ 1 | 159 (39.9) | 9439 (35.8) | |
Year of Cancer Incidence | |||
2000 | 43 (10.8) | 2562 (9.7) | 0.004a |
2001 | 39 (9.8) | 2389 (9.1) | |
2002 | 42 (10.6) | 2624 (10.0) | |
2003 | 57 (14.3) | 2600 (9.9) | |
2004 | 35 (8.8) | 2607 (9.9) | |
2005 | 42 (10.6) | 2609 (9.9) | |
2006 | 38 (9.5) | 2738 (10.4) | |
2007 | 46 (11.6) | 2716 (10.3) | |
2008 | 35 (8.8) | 2700 (10.3) | |
2009 | 21 (5.3) | 2788 (10.6) | |
Treated with Surgery | |||
No | 168 (42.2) | 21,540 (81.8) | < 0.001 |
Yes | 210 (52.8) | 2505 (9.5) | |
Not known | 20 (5.0) | 2288 (8.7) | |
Treated with Radiotherapy | |||
No | 280 (70.4) | 15,510 (58.9) | < 0.001 |
Yes | 53 (13.3) | 7876 (29.9) | |
Not known | 65 (16.3) | 2947 (11.2) | |
Treated with Chemotherapy | |||
No | 283 (71.1) | 17,342 (65.9) | < 0.001 |
Yes | 56 (14.1) | 6468 (24.6) | |
Not known | 59 (14.8) | 2523 (9.6) | |
Therapy objectives | |||
Curative | 140 (35.2) | 2481 (9.4) | < 0.001 |
Palliative | 184 (46.2) | 20,657 (78.5) | |
Not known | 74 (18.6) | 3195 (12.1) |
Univariable Odds Ratio (95% CI) | P value | Multivariable Odds Ratio (95% CI) | P value | |
---|---|---|---|---|
Age at Incidence Quintile* | ||||
15–62 | 1 | 1 | ||
63–69 | 1.21 (0.93–1.57) | 0.153 | 1.15 (0.88–1.51) | 0.294 |
70–74 | 0.90 (0.67–1.20) | 0.463 | 0.87 (0.64–1.17) | 0.360 |
75–80 | 0.62 (0.46–0.85) | 0.003 | 0.69 (0.49–0.94) | 0.019 |
> 80 | 0.16 (0.09–0.28) | < 0.001 | 0.21 (0.12–0.37) | < 0.001 |
Sex | ||||
Male | 1 | 1 | ||
Female | 0.71 (0.58–0.87) | 0.001 | 0.73 (0.59–0.90) | 0.003 |
SIMD Quintile | ||||
1 (Most deprived) | 1 | 1 | ||
2 | 1.16 (0.90–1.49) | 0.249 | 1.16 (0.89–1.50) | 0.269 |
3 | 1.30 (0.98–1.73) | 0.068 | 1.37 (1.03–1.83) | 0.033 |
4 | 1.15 (0.82–1.62) | 0.425 | 1.31 (0.92–1.86) | 0.132 |
5 (Most affluent) | 1.04 (0.70–1.55) | 0.829 | 1.08 (0.69–1.55) | 0.696 |
Therapy Objectives | ||||
Curative | 1 | 1 | ||
Palliative | 0.16 (0.13–0.20) | < 0.001 | 1.08 (0.75–1.54) | 0.682 |
Not known | 0.41 (0.31–0.55) | < 0.001 | 1.54 (1.08–2.20) | 0.017 |
Treated with Surgery | ||||
No | 1 | 1 | ||
Yes | 10.75 (8.7–13.2) | < 0.001 | 7.23 (5.14–10.2) | < 0.001 |
Not known | 1.12 (0.70 - 1.79) | 0.631 | 0.50 (0.27–0.91) | 0.025 |
Treated with Radiotherapy | ||||
No | 1 | 1 | ||
Yes | 0.37 (0.28–0.50) | < 0.001 | 0.54 (0.39–0.73) | < 0.001 |
Not known | 1.22 (0.93–1.60) | 0.150 | 1.32 (0.78–2.24) | 0.298 |
Treated with Chemotherapy | ||||
No | 1 | 1 | ||
Yes | 0.53 (0.40–0.71) | < 0.001 | 0.52 (0.38–0.70) | < 0.001 |
Not known | 1.43 (1.08–1.90) | 0.013 | 1.07 (0.62–1.84) | 0.814 |
Charlson Co-morbidity Index | ||||
0 | 1 | 1 | ||
≥ 1 | 1.19 (0.97–1.46) | 0.091 | 1.22 (0.99–1.51) | 0.059 |